Thank you for your patience as we work to resolve bugs and issues on the new Register. To see if your issue has already been reported, please view the list of known issues.
This item is authorised by the following title:
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2023 (No. 2)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2023 (No. 1)
National Health (Growth Hormone Program) Special Arrangement Amendment (Mecasermin and Somatrogon) Instrument 2022
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2022 (No. 1)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 2)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2020 (No. 1) (PB 6 of 2020)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 3) (PB 109 of 2019)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 2) (PB 80 of 2019)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 1) (PB 22 of 2019)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 3) (PB 113 of 2018)